These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 443053)

  • 1. [Mixing kinetics derived by computer elaboration of powder mixing data].
    Kata M; Boda K; Eller J
    Acta Pharm Hung; 1979 Mar; 49(2):57-61. PubMed ID: 443053
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterizing powder mixing processes utilizing compartment models.
    Portillo PM; Muzzio FJ; Ierapetritou MG
    Int J Pharm; 2006 Aug; 320(1-2):14-22. PubMed ID: 16698203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The determination and interpretation of in-vitro dissolution behavior of pharmaceutical substances. 1. Powders, mixtures and granules].
    Voigt R; Eitz K; Bornschein M
    Pharmazie; 1987 Jan; 42(1):22-5. PubMed ID: 3575398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ordered mixing (author's transl)].
    Verraes J; Kinget R
    J Pharm Belg; 1979; 34(5):297-307. PubMed ID: 512832
    [No Abstract]   [Full Text] [Related]  

  • 5. [Industrial-scale experiments on powder mixing].
    Wayer M; Pap A; Kata M
    Acta Pharm Hung; 1980 Jan; 50(1):25-31. PubMed ID: 7361554
    [No Abstract]   [Full Text] [Related]  

  • 6. Triboelectrification of pharmaceutical powders by particle impact.
    Watanabe H; Ghadiri M; Matsuyama T; Ding YL; Pitt KG; Maruyama H; Matsusaka S; Masuda H
    Int J Pharm; 2007 Apr; 334(1-2):149-55. PubMed ID: 17141989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interactive powder mixtures].
    Zatloukal Z
    Ceska Slov Farm; 2004 Jul; 53(4):165-71. PubMed ID: 15369226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new expert systems (SeDeM diagram) for control batch powder formulation and preformulation drug products.
    Pérez P; Suñé-Negre JM; Miñarro M; Roig M; Fuster R; García-Montoya E; Hernández C; Ruhí R; Ticó JR
    Eur J Pharm Biopharm; 2006 Nov; 64(3):351-9. PubMed ID: 16949262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unlocking interpretation in near infrared multivariate calibrations by orthogonal partial least squares.
    Stenlund H; Johansson E; Gottfries J; Trygg J
    Anal Chem; 2009 Jan; 81(1):203-9. PubMed ID: 19117451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Considerations about the theoretically expected crushing strength of tablets from binary powder mixtures: double layer tablets versus arithmetic additivity rule.
    Belda PM; Mielck JB
    Eur J Pharm Biopharm; 2006 Nov; 64(3):343-50. PubMed ID: 16914296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An instrumental method for the monitoring of mixing processes [proceedings].
    Seager H; Fisher H; Davies J
    J Pharm Pharmacol; 1976 Dec; 28 Suppl():64P. PubMed ID: 12342
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on packing of powder. IV. The use of digital computer for simulation of powder compaction on two-dimensional model (author's transl)].
    Sunada H; Otsuka A
    Yakugaku Zasshi; 1976 Jul; 96(7):899-904. PubMed ID: 987227
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitative solid-state analysis of three solid forms of ranitidine hydrochloride in ternary mixtures using Raman spectroscopy and X-ray powder diffraction.
    Chieng N; Rehder S; Saville D; Rades T; Aaltonen J
    J Pharm Biomed Anal; 2009 Jan; 49(1):18-25. PubMed ID: 19081220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-time monitoring of powder mixing in a convective blender using non-invasive reflectance NIR spectrometry.
    Bellamy LJ; Nordon A; Littlejohn D
    Analyst; 2008 Jan; 133(1):58-64. PubMed ID: 18087614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cohesive, multicomponent, dense powder flow characterization by NIR.
    Benedetti C; Abatzoglou N; Simard JS; McDermott L; Léonard G; Cartilier L
    Int J Pharm; 2007 May; 336(2):292-301. PubMed ID: 17240094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quil A-lipid powder formulations releasing ISCOMs and related colloidal structures upon hydration.
    Demana PH; Davies NM; Hook S; Rades T
    J Control Release; 2005 Mar; 103(1):45-59. PubMed ID: 15710499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental determination of the diffusion boundary layer width of micron and submicron particles.
    Galli C
    Int J Pharm; 2006 Apr; 313(1-2):114-22. PubMed ID: 16529883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The difficulty in the assessment of the compression behaviour of powder mixtures: Double layer tablets versus arithmetic additivity rule.
    Belda PM; Mielck JB
    Eur J Pharm Biopharm; 2005 May; 60(1):133-45. PubMed ID: 15848065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel ultra-rapid freezing particle engineering process for enhancement of dissolution rates of poorly water-soluble drugs.
    Overhoff KA; Engstrom JD; Chen B; Scherzer BD; Milner TE; Johnston KP; Williams RO
    Eur J Pharm Biopharm; 2007 Jan; 65(1):57-67. PubMed ID: 16987642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of powder processing on performance of fenofibrate formulations.
    Jain RA; Brito L; Straub JA; Tessier T; Bernstein H
    Eur J Pharm Biopharm; 2008 Jun; 69(2):727-34. PubMed ID: 18226885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.